(Q46196655)

20 December 2017

title

A randomized, controlled trial to investigate the effect of ciclesonide and beclomethasone dipropionate on eye lens opacity (English)

1 reference

20 December 2017

beclomethasone dipropionate

main subject

1 reference

Leo T Chylack

1

1 reference

20 December 2017

Gary N Gross

series ordinal

2

1 reference

20 December 2017

Andrew Pedinoff

series ordinal

3

1 reference

20 December 2017

Ciclesonide Lenticular Safety Study Group

series ordinal

4

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

20 December 2017

published in

Journal of Asthma

1 reference

20 December 2017

volume

45

1 reference

20 December 2017

issue

10

1 reference

20 December 2017

page(s)

893-902

1 reference

20 December 2017

Inhaled steroids for children: effects on growth, bone, and adrenal function

cites work

1 reference

https://api.crossref.org/works/10.1080%2F02770900802353636

Inhaled corticosteroids: past lessons and future issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802353636

Systemic side effects of inhaled corticosteroids in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802353636

Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802353636

The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802353636

Standardization of Spirometry, 1994 Update. American Thoracic Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802353636

Cataract progression in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802353636

Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone : a cross-over study in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802353636

Two-dimensional and three-dimensional imaging show ciclesonide has high lung deposition and peripheral distribution: a nonrandomized study in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802353636

Use of inhaled corticosteroids and the risk of cataracts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802353636

Association of inhaled corticosteroid use with cataract extraction in elderly patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802353636

A population based case-control study of cataract and inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802353636

Risk factors for incident nuclear opacities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802353636

Risk factors for age-related cataracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802353636

Risk factors for incident cortical and posterior subcapsular lens opacities in the Barbados Eye Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802353636

Once-daily ciclesonide 80 or 320 microg for 12 weeks is safe and effective in patients with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802353636

Maintenance of asthma control by once-daily inhaled ciclesonide in adults with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02770900802353636

10.1080/02770900802353636

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017